Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Urovo Technology Co., Ltd. (300531.SZ)

Compare
12.19
+0.07
+(0.58%)
At close: April 18 at 3:04:49 PM GMT+8
Loading Chart for 300531.SZ
  • Previous Close 12.12
  • Open 12.33
  • Bid 12.21 x --
  • Ask 12.22 x --
  • Day's Range 12.07 - 12.55
  • 52 Week Range 8.72 - 20.70
  • Volume 7,571,300
  • Avg. Volume 7,723,345
  • Market Cap (intraday) 3.997B
  • Beta (5Y Monthly) 0.57
  • PE Ratio (TTM) --
  • EPS (TTM) -0.71
  • Earnings Date --
  • Forward Dividend & Yield 0.05 (0.41%)
  • Ex-Dividend Date May 29, 2024
  • 1y Target Est --

Urovo Technology Co., Ltd. manufactures and sells mobile computers and payment terminals in China and internationally. It offers mobile printers, RFID readers, tablets, healthcare, and wearable devices, as well as provides terminal management software. The company also provides technical support and after sales services. Its products are used in transportation and logistics, warehousing, retail, finance, government enforcement, healthcare, and other sectors. The company was founded in 2006 and is headquartered in Shenzhen, China. Urovo Technology Co., Ltd. is a subsidiary of Urovo Technology (Hong Kong) Holdings Limited.

www.urovo.com

1,373

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 300531.SZ

View More

Performance Overview: 300531.SZ

Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

300531.SZ
12.62%
SSE Composite Index (000001.SS)
2.24%

1-Year Return

300531.SZ
23.52%
SSE Composite Index (000001.SS)
6.59%

3-Year Return

300531.SZ
13.05%
SSE Composite Index (000001.SS)
2.54%

5-Year Return

300531.SZ
24.52%
SSE Composite Index (000001.SS)
15.44%

Compare To: 300531.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300531.SZ

View More

Valuation Measures

Annual
As of 4/18/2025
  • Market Cap

    4.00B

  • Enterprise Value

    3.45B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.26

  • Price/Book (mrq)

    2.66

  • Enterprise Value/Revenue

    2.69

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -18.10%

  • Return on Assets (ttm)

    1.21%

  • Return on Equity (ttm)

    -15.21%

  • Revenue (ttm)

    1.28B

  • Net Income Avi to Common (ttm)

    -232.13M

  • Diluted EPS (ttm)

    -0.71

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.17B

  • Total Debt/Equity (mrq)

    40.93%

  • Levered Free Cash Flow (ttm)

    -137.9M

Research Analysis: 300531.SZ

View More

Company Insights: 300531.SZ

Research Reports: 300531.SZ

View More

People Also Watch